Lu-177 ethylenedicysteine amifostine

N/A

Report date: 2025/11/28 17:54:17

NME

Base Information

Drug NameLu-177 ethylenedicysteine amifostine

Drug Alias Name(177)Lu ethylenedicysteine amifostine177Lu ethylenedicysteine amifostine177Lu-EC-AmifostineEthylenedicysteine amifostine-Lutetium-177Lutetium 177 ethylenedicysteine amifostine

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionSingle-photon emission-computed tomography enhancersPositron-emission tomography enhancersOxygen radical scavengers

TargetsUpdating

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellPoint LLC

China Registration ClassN/A

Develop Information

Active CompaniesCellPoint LLC

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A